Although we described possible O‐GlcNAc regulatory mechanisms, the precise regulatory mechanism of decreased OGA binding to c‐Fos in response to Aβ and altered O‐GlcNAc cycling in AD needs to be further studied. Here, FOS is linked to Alzheimer disease.